| 000 | 01061 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514183008.0 | ||
| 264 | 0 | _c20041019 | |
| 008 | 200410s 0 0 eng d | ||
| 022 | _a0145-5680 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAslan, M | |
| 245 | 0 | 0 |
_aOxidant-mediated impairment of nitric oxide signaling in sickle cell disease--mechanisms and consequences. _h[electronic resource] |
| 260 |
_bCellular and molecular biology (Noisy-le-Grand, France) _cFeb 2004 |
||
| 300 |
_a95-105 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnemia, Sickle Cell _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xtherapeutic use |
| 650 | 0 | 4 |
_aCytoskeletal Proteins _xmetabolism |
| 650 | 0 | 4 |
_aFree Radicals _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
| 650 | 0 | 4 |
_aOxidants _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aFreeman, B A | |
| 773 | 0 |
_tCellular and molecular biology (Noisy-le-Grand, France) _gvol. 50 _gno. 1 _gp. 95-105 |
|
| 999 |
_c14757611 _d14757611 |
||